Immune response to Philadelphia chromosome-positive acute lymphoblastic leukemia induced by expression of CD80, interleukin 2, and granulocyte-macrophage colony-stimulating factor

Human Gene Therapy

Volumn 9, Issue 14, 1998, Pages 2049-2062

  Stripecke, R ^a   Skelton, D C ^a   Gruber, T ^a   Afar, D ^b   Pattengale, P K ^a   Witte, O N ^c   Kohn, D B ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UroGenesys Inc   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOSTIMULATING AGENT; INTERLEUKIN 2;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EXPRESSION VECTOR; GENE TRANSFER; GENETIC TRANSDUCTION; IMMUNE DEFICIENCY; LEUKEMIA CELL; MALE; MOUSE; NONHUMAN; PHILADELPHIA 1 CHROMOSOME; RETROVIRUS; TUMOR IMMUNITY;

ANIMALIA; MURINAE; UNIDENTIFIED RETROVIRUS;

EID: 0032552418     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.14-2049     Document Type: Article

References (17)

1. BAUMGARTEN, E., SCHMID, H., POHL, U., BRZOSKA, J., LINDERKAMP, C, SIEGERT, W., and HENZE, G. (1994). Low-dose natural interleukin-2 and recombinant interferon-gamma following autologous bone marrow grafts in pediatric patients with high-risk acute leukemia. Leukemia 8, 850-855.
2. BUNNEL, B.A., MULL, L.M., DONAHUE, R.E., BLAESE, R.M., and MORGAN, R.A. (1995). High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 92, 7739-7743.
3. CARDOSO, A.A., SCHULTZE, J.L., BOUSSIOTIS, V.A., FREEMAN, G.J., SEAMON, M.J., LASZLO, S., BILLET, A., SALLAN, S.E., GRIEBEN, J.G., and NADLER, L.M. (1996). Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen. Blood 88, 41-48.
4. CARDOSO, A.A., SEAMON, M.J., AFONSO, H.M., GHIA, P., BOUSSIOTIS, V.A., FREEMAN, G.J., GRIEBEN, J.G., SALLAN, S.E., and NADLER, L.M. (1997). Ex vivo generation of human antipre-B leukemia-specific autologous cytolytic T cells. Blood 90, 549-561.
5. CHEN, L., McGOWAN, P., ASHE, S., JOHNSTON, J., LI, Y., HELLSTROEM, I., and HELLSTROEM, K.E. (1994). Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J. Exp. Med. 179, 523-532.
6. CHOUDURY, A., GAYEWSKI, J.L., LIANG, J.C., POPAT, U., CLAXTON, D.F., KLICHE, K.-L., ANDREEFF, M., and CHAMPLIN, R.E. (1997). use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 89, 1133-1142.
7. DILOO, D., BROWN, M., ROSKROW, M., ZHONG, W., HOLLADAY, M., HOLDEN, W., and BRENNER, M. (1997). CD40 ligand induces an antileukemia immune response in vivo. Blood 80, 1927-1933.
8. DRANOFF, G., JAFEE, E., LAZENBY, A., GOLUMBEK, P., LEVITSKY, H., BROSE, K., JACKSON, V., HAMADA, H., PARDOLL, D., and MULLIGAN, R.C. (1993). Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific and long lasting anti-tumor immunity. Proc. Natl. Acad. Sci. U.S.A. 90, 3539-3543.
9. DUNUSSI-JOANNOPOULOS, K., WEINSTEIN, H.J., NICKERSON, P.W., STROM, T.B., BUKAROFF, J., CROOP, J.M., and ARCECI, R.J. (1996). Irradiated B7-1 transduced primary acute myelogenous leukemia (AML) cells can be used as therapeutic vaccines in murine AML. Blood 87, 2938-2946.
10. FEARON, E.R., PARDOLL, D.M., ITAYA, T., GOLUMBEK, P., LEVITSKY, H.I., SIMONS, J.W., KARASUYAMA, H., VOGELSTEIN, B., and FROST, P. (1990). Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 60, 397-403.
11. FINDLEY, H., MAGEED, A.A., NASR, S.A., and RAGAB, A.H. (1988). Recombinant interleukin-2 activates peripheral blood lymphocytes from children with acute leukemia to kill autologous leukemia cells. Cancer 62, 1928-1931.
12. FREEDMAN, M.H., GRUNBERGER, T., CORREA, P., AXELRAD, A.A., DUBE, I.D., and COHEN, A. (1993). Autocrine and paracrine growth control by granulocyte-monocyte colony-stimulating factor of acute lymphoblastic cells. Blood 81, 3068-3075.
13. GOGA, A., McLAUGHLIN, J., AFAR, D.E.H., SAFRAN, D.C., and WITTE, O.N. (1995). Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogens. Cell 82, 981-988.
14. HEISTERKAMP, N., JENSTER, G., TEN HOEVE, J., ZOVICH, D., PATTENGALE, P., and GROFFEN, J. (1990). Acute leukemia in BCR/ABL transgenic mice. Nature (London) 344, 251-253.
15. HIRANO, N., TAKASHI, T., OHTAKE, S., HIRASHIMA, K., EMI, N., SAITO, K., HIRANO, M., SHINOHARA, K., TAKEUSH, M., TAKETAZU, F., TSUNODA, S., OGURA, M., OMINE, M., SAITO, T., YAZAKI, Y., UEDA, R., and HIRAI, H. (1996). Expression of costimulatory molecules in human leukemias. Leukemia 10, 1168-1176.
16. TEN BOSH, G.J.A., JOOSTEN, A.M., KESSLER, J.H., MELIEF, C.J.M., and LEEKSMA, O.C. (1996). Recognition of BCR-ABL positive leukemic blasts by human CD4+ T cells elicited by primary in vitro immunization with a BCR-ABL breakpoint peptide. Blood 88, 3522-3527.
17. TOWNSED, S.E., SU, F.W., ATHERTON, J.M., and ALLISON, J.P. (1994). Specificity and longevity of antitumor immune responses induced by B7-transfected tumors. Cancer Res. 54, 6477-6483.